RATOFF STEVEN B 4
4 · EAGLE PHARMACEUTICALS, INC. · Filed Dec 20, 2017
Insider Transaction Report
Form 4
RATOFF STEVEN B
Director
Transactions
- Exercise/Conversion
Common Stock
2017-12-18$0.90/sh+2,340$2,106→ 15,664 total - Exercise/Conversion
Stock Option (Right to Buy)
2017-12-18−2,340→ 0 totalExercise: $0.90Exp: 2018-03-06→ Common Stock (2,340 underlying)
Footnotes (1)
- [F1]These shares are fully vested and immediately exercisable.